Literature DB >> 16775360

High rate of genetic recombination in murine leukemia virus: implications for influencing proviral ploidy.

Jianling Zhuang1, Sayandip Mukherjee, Yacov Ron, Joseph P Dougherty.   

Abstract

A significant difference in the recombination rates between human immunodeficiency virus type 1 (HIV-1) and the gammaretroviruses was previously reported, with the former being 10 to 100 times more recombinogenic. It is possible that preferential copackaging of homodimers in the case of gammaretroviruses, like murine leukemia virus (MLV), led to the underestimation of their rates of recombination. To reexamine the recombination rates for MLV, experiments were performed to control for nonrandom copackaging of viral RNA, and it was found that MLV and HIV-1 exhibit similar crossover rates. The implications for control of proviral ploidy and preferential recombination during minus-strand DNA synthesis are discussed.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16775360      PMCID： PMC1488982          DOI： 10.1128/JVI.00273-06

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  29 in total

1.  High rate of genetic rearrangement during replication of a Moloney murine leukemia virus-based vector.

Authors:  A Varela-Echavarría; C M Prorock; Y Ron; J P Dougherty
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

2.  The first strand transfer during HIV-1 reverse transcription can occur either intramolecularly or intermolecularly.

Authors:  J L van Wamel; B Berkhout
Journal:  Virology       Date:  1998-05-10       Impact factor: 3.616

3.  Homologous recombination occurs in a distinct retroviral subpopulation and exhibits high negative interference.

Authors:  W S Hu; E H Bowman; K A Delviks; V K Pathak
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

4.  Determination of the site of first strand transfer during Moloney murine leukemia virus reverse transcription and identification of strand transfer-associated reverse transcriptase errors.

Authors:  D Kulpa; R Topping; A Telesnitsky
Journal:  EMBO J       Date:  1997-02-17       Impact factor: 11.598

5.  Ordered interstrand and intrastrand DNA transfer during reverse transcription.

Authors:  A T Panganiban; D Fiore
Journal:  Science       Date:  1988-08-26       Impact factor: 47.728

6.  A competition immunoassay for characterizing the reverse transcriptase of mammalian RNA tumor viruses.

Authors:  A Panet; Z Kra-Oz
Journal:  Virology       Date:  1978-08       Impact factor: 3.616

7.  Fitness of RNA virus decreased by Muller's ratchet.

Authors:  L Chao
Journal:  Nature       Date:  1990-11-29       Impact factor: 49.962

8.  Broad spectrum of in vivo forward mutations, hypermutations, and mutational hotspots in a retroviral shuttle vector after a single replication cycle: substitutions, frameshifts, and hypermutations.

Authors:  V K Pathak; H M Temin
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

9.  Comparison of Moloney murine leukemia virus mutation rate with the fidelity of its reverse transcriptase in vitro.

Authors:  A Varela-Echavarría; N Garvey; B D Preston; J P Dougherty
Journal:  J Biol Chem       Date:  1992-12-05       Impact factor: 5.157

10.  Point mutations in Moloney murine leukemia virus envelope protein: effects on infectivity, virion association, and superinfection resistance.

Authors:  R D Berkowitz; S P Goff
Journal:  Virology       Date:  1993-10       Impact factor: 3.616
View more
  15 in total

1.  RNA structures facilitate recombination-mediated gene swapping in HIV-1.

Authors:  Etienne Simon-Loriere; Darren P Martin; Kevin M Weeks; Matteo Negroni
Journal:  J Virol       Date:  2010-09-29       Impact factor: 5.103

2.  High frequency of genetic recombination is a common feature of primate lentivirus replication.

Authors:  Jianbo Chen; Douglas Powell; Wei-Shau Hu
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

3.  Latent HIV-1 can be reactivated by cellular superinfection in a Tat-dependent manner, which can lead to the emergence of multidrug-resistant recombinant viruses.

Authors:  Daniel A Donahue; Sophie M Bastarache; Richard D Sloan; Mark A Wainberg
Journal:  J Virol       Date:  2013-06-26       Impact factor: 5.103

4.  Effects of identity minimization on Moloney murine leukemia virus template recognition and frequent tertiary template-directed insertions during nonhomologous recombination.

Authors:  Nisha K Duggal; Leslie Goo; Steven R King; Alice Telesnitsky
Journal:  J Virol       Date:  2007-09-05       Impact factor: 5.103

5.  Proviral progeny of heterodimeric virions reveal a high crossover rate for human immunodeficiency virus type 2.

Authors:  Sayandip Mukherjee; Hui-Ling Rose Lee; Yacov Ron; Joseph P Dougherty
Journal:  J Virol       Date:  2006-10-04       Impact factor: 5.103

6.  Recombinant origin of the retrovirus XMRV.

Authors:  Tobias Paprotka; Krista A Delviks-Frankenberry; Oya Cingöz; Anthony Martinez; Hsing-Jien Kung; Clifford G Tepper; Wei-Shau Hu; Matthew J Fivash; John M Coffin; Vinay K Pathak
Journal:  Science       Date:  2011-05-31       Impact factor: 47.728

Review 7.  XMRV and prostate cancer--a 'final' perspective.

Authors:  Karen S Sfanos; Amanda L Aloia; Angelo M De Marzo; Alan Rein
Journal:  Nat Rev Urol       Date:  2012-01-10       Impact factor: 14.432

8.  Recombinant Origins of Pathogenic and Nonpathogenic Mouse Gammaretroviruses with Polytropic Host Range.

Authors:  Devinka Bamunusinghe; Qingping Liu; Ronald Plishka; Michael A Dolan; Matthew Skorski; Andrew J Oler; Venkat R K Yedavalli; Alicia Buckler-White; Janet W Hartley; Christine A Kozak
Journal:  J Virol       Date:  2017-10-13       Impact factor: 5.103

Review 9.  Retroviral RNA dimerization and packaging: the what, how, when, where, and why.

Authors:  Silas F Johnson; Alice Telesnitsky
Journal:  PLoS Pathog       Date:  2010-10-07       Impact factor: 6.823

10.  Accuracy estimation of foamy virus genome copying.

Authors:  Kathleen Gärtner; Tatiana Wiktorowicz; Jeonghae Park; Ayalew Mergia; Axel Rethwilm; Carsten Scheller
Journal:  Retrovirology       Date:  2009-04-06       Impact factor: 4.602
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.